Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

An Inducible Leukemia-Associated Transcription Factor Facilitates Large-Scale Ex Vivo Generation of Functional Human Macrophages

Blood (2021) 138 (Supplement 1): 2805.

https://doi.org/10.1182/blood-2021-148336

Published: 2021

Journal Articles

Characterization of Somatic Mosaicism and Mutational Profiling of Clonal Hematopoiesis Compared to MDS and sAML Depicts Diversities of Clonal Evolution

Blood (2021) 138 (Supplement 1): 3278.

https://doi.org/10.1182/blood-2021-152187

Published: 2021

Journal Articles

CHIP and hips: clonal hematopoiesis is common in patients undergoing hip arthroplasty and is associated with autoimmune disease

Blood (2021) 138 (18): 1727–1732.

https://doi.org/10.1182/blood.2020010163

Published: 2021

Includes: Supplemental data

Journal Articles

Loss of ZBTB7A Facilitates RUNX1/RUNX1T1-Dependent Clonal Expansion and Sensitizes for Metabolic Inhibition

Enric Redondo Monte, MSc, BSc, Anja Wilding, MSc, Georg Leubolt, MSc, Luise Hartmann, PhD, Sayantanee Dutta, PhD, Wolfgang Hiddemann, Lingping Chen-Wichmann, PhD, Christian Wichmann, MD, Philipp A. Greif, MD PD

Blood (2018) 132 (Supplement 1): 1499.

https://doi.org/10.1182/blood-2018-99-114789

Published: 2018

Journal Articles

Therapy-Related Myeloid Neoplasms (tMN) Following Treatment of Acute Myeloid Leukemia (AML): Exome Sequencing Reveals the Presence of an Ancestral Clone Refractory to Chemotherapy

Luise Hartmann, PhD, Niroshan Nadarajah, Manja Meggendorfer, PhD, Alexander Höllein, MD, Calogero Vetro, MD, Anna Stengel, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2018) 132 (Supplement 1): 1462.

https://doi.org/10.1182/blood-2018-99-112924

Published: 2018

Journal Articles

Molecular Characterization of Acute Myeloid Leukemia (AML) Patients Who Relapse More Than 3 Years after Diagnosis: An Exome Sequencing Study of 31 Patients

Luise Hartmann, PhD, Niroshan Nadarajah, Manja Meggendorfer, PhD, Anna Stengel, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2018) 132 (Supplement 1): 1463.

https://doi.org/10.1182/blood-2018-99-112940

Published: 2018

Journal Articles

Comprehensive Molecular Characterization of Myeloid Malignancies with 9q Deletion

Luise Hartmann, PhD, Torsten Haferlach, MD, Manja Meggendorfer, PhD, Annette Fasan, PhD, Anna Stengel, PhD, Melanie Zenger, Kathleen Zieschang, Wolfgang Kern, MD, Claudia Haferlach, MD

Blood (2017) 130 (Supplement 1): 2953.

https://doi.org/10.1182/blood.V130.Suppl_1.2953.2953

Published: 2017

Journal Articles

PS29MRC - a Novel Predictive Score for Response to Therapy in Acute Myeloid Leukemia

Blood (2016) 128 (22): 1209.

https://doi.org/10.1182/blood.V128.22.1209.1209

Published: 2016

Journal Articles

Evolutionary Patterns of Cytogenetically Normal Acute Myeloid Leukemia Correlate with Time to Relapse

Blood (2016) 128 (22): 288.

https://doi.org/10.1182/blood.V128.22.288.288

Published: 2016

Journal Articles

Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia

Blood (2016) 128 (5): 686–698.

https://doi.org/10.1182/blood-2016-01-693879

Published: 2016

Includes: Supplemental data

Journal Articles

DNMT3A Mutations Associate with Shorter Survival and Modulate the Prognostic Impact of Mutated NPM1: an Analysis Based on Comprehensive Mutational Screening of 660 AML Patients Treated on German AML Cooperative Group (AMLCG) Trials

Blood (2015) 126 (23): 3815.

https://doi.org/10.1182/blood.V126.23.3815.3815

Published: 2015

Journal Articles

Detection of Chromosomal Aberrations in Acute Myeloid Leukemia By Copy Number Alteration Analysis of Exome Sequencing Data

Sebastian Vosberg, Luise Hartmann, MSc, Stephanie Schneider, PhD, Klaus H. Metzeler, MD, Bianka Ksienzyk, Kathrin Bräundl, Martin Neumann, MD, Claudia D Baldus, MD, Alexander Graf, PhD, Stefan Krebs, PhD, Helmut Blum, PhD, Karsten Spiekermann, MD, Stefan K. Bohlander, MD, Ulrich Mansmann, PhD, Philipp A. Greif, MD

Blood (2015) 126 (23): 3859.

https://doi.org/10.1182/blood.V126.23.3859.3859

Published: 2015

Journal Articles

Mutations of Genes Linked to Epigenetic Regulation Are Frequently Gained in Relapsed Cytogenetically Normal Acute Myeloid Leukemia

Luise Hartmann, MSc, Sebastian Vosberg, Klaus H. Metzeler, MD, Daniela Schumacher, Friederike Pastore, MD, Kathrin Bräundl, Evelyn Zellmeier, Bianka Ksienzyk, Nikola P Konstandin, PhD, Stephanie Schneider, PhD, Stefan Krebs, PhD, Alexander Graf, PhD, Helmut Blum, PhD, Martin Neumann, MD, Claudia D Baldus, MD, Stefan K. Bohlander, MD, Wolfgang Hiddemann, MD, Karsten Spiekermann, MD, Philipp A. Greif, MD

Blood (2015) 126 (23): 690.

https://doi.org/10.1182/blood.V126.23.690.690

Published: 2015

Journal Articles

Myeloid Cell Maturation Is Disrupted By Monosomy 7 or By Gain of Additional Genetic Aberrations during Clonal Evolution in Myelodysplastic Syndromes.

Barbara Katharina Zehentner, PhD, Jevon Cutler, Luise Hartmann, MS, Krystal Johnson, MS, Richard Bennington, Wayne Fritschle, MT, Keely Ghirardelli, Lisa Broderson, PhD, Doug Chapman, Christine F Stephenson, PhD, FACMG, Monica E de Baca, MD, Timothy Singleton, MD, Denise A. Wells, MD, Michael R. Loken, PhD

Blood (2014) 124 (21): 3244.

https://doi.org/10.1182/blood.V124.21.3244.3244

Published: 2014

Journal Articles

SNP/CGH Microarray Analysis in MDS: Correlation with Conventional Cytogenetic, FISH and Flow Cytometry Findings

Barbara Katharina Zehentner, PhD, Lisa Eidenschink Brodersen, PhD, Christine F Stephenson, PhD, FACMG, Jevon Cutler, Monica E. de Baca, MD, Andrew Menssen, Kelle Hammock, Krystal Johnson, MS, Luise Hartmann, MS, Michael R Loken, PhD, Denise A. Wells, MD

Blood (2014) 124 (21): 5592.

https://doi.org/10.1182/blood.V124.21.5592.5592

Published: 2014

Journal Articles

A Comparative Assessment of Flow Cytometric Scoring Systems in MDS

Lisa Eidenschink Brodersen, PhD, Andrew Menssen, Barbara Katharina Zehentner, PhD, Christine F Stephenson, PhD, FACMG, Monica E. de Baca, MD, Krystal Johnson, MS, Timothy Singleton, MD, Luise Hartmann, MS, Michael R. Loken, PhD, Denise A. Wells, MD

Blood (2014) 124 (21): 5589.

https://doi.org/10.1182/blood.V124.21.5589.5589

Published: 2014

Journal Articles

Genetic Evolution of Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) during Therapy and Relapse: An Exome Sequencing Study of 47 Cases

Blood (2014) 124 (21): 17.

https://doi.org/10.1182/blood.V124.21.17.17

Published: 2014

Journal Articles

BCR-ABL1-like Acute Lymphoblastic Leukemia Is Associated with IKZF1 and JAK2 Alterations and inferior Outcome in Adults

Blood (2014) 124 (21): 3787.

https://doi.org/10.1182/blood.V124.21.3787.3787

Published: 2014

Journal Articles

Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis

Blood (2014) 124 (8): 1304–1311.

https://doi.org/10.1182/blood-2013-12-540716

Published: 2014

Includes: Supplemental data

NARROW

An Inducible Leukemia-Associated Transcription Factor Facilitates Large-Scale Ex Vivo Generation of Functional Human Macrophages

Characterization of Somatic Mosaicism and Mutational Profiling of Clonal Hematopoiesis Compared to MDS and sAML Depicts Diversities of Clonal Evolution

CHIP and hips: clonal hematopoiesis is common in patients undergoing hip arthroplasty and is associated with autoimmune disease

Loss of ZBTB7A Facilitates RUNX1/RUNX1T1-Dependent Clonal Expansion and Sensitizes for Metabolic Inhibition

Therapy-Related Myeloid Neoplasms (tMN) Following Treatment of Acute Myeloid Leukemia (AML): Exome Sequencing Reveals the Presence of an Ancestral Clone Refractory to Chemotherapy

Molecular Characterization of Acute Myeloid Leukemia (AML) Patients Who Relapse More Than 3 Years after Diagnosis: An Exome Sequencing Study of 31 Patients

Comprehensive Molecular Characterization of Myeloid Malignancies with 9q Deletion

PS29MRC - a Novel Predictive Score for Response to Therapy in Acute Myeloid Leukemia

Evolutionary Patterns of Cytogenetically Normal Acute Myeloid Leukemia Correlate with Time to Relapse

Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia

DNMT3A Mutations Associate with Shorter Survival and Modulate the Prognostic Impact of Mutated NPM1: an Analysis Based on Comprehensive Mutational Screening of 660 AML Patients Treated on German AML Cooperative Group (AMLCG) Trials

Detection of Chromosomal Aberrations in Acute Myeloid Leukemia By Copy Number Alteration Analysis of Exome Sequencing Data

Mutations of Genes Linked to Epigenetic Regulation Are Frequently Gained in Relapsed Cytogenetically Normal Acute Myeloid Leukemia

Myeloid Cell Maturation Is Disrupted By Monosomy 7 or By Gain of Additional Genetic Aberrations during Clonal Evolution in Myelodysplastic Syndromes.

SNP/CGH Microarray Analysis in MDS: Correlation with Conventional Cytogenetic, FISH and Flow Cytometry Findings

A Comparative Assessment of Flow Cytometric Scoring Systems in MDS

Genetic Evolution of Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) during Therapy and Relapse: An Exome Sequencing Study of 47 Cases

BCR-ABL1-like Acute Lymphoblastic Leukemia Is Associated with IKZF1 and JAK2 Alterations and inferior Outcome in Adults

Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only